{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:21:28Z","timestamp":1786990888487,"version":"build-2736575974"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,5,15]],"date-time":"2027-05-15T00:00:00Z","timestamp":1810339200000},"content-version":"am","delay-in-days":348,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijrobp.2025.07.1408","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T23:23:30Z","timestamp":1753313010000},"page":"612-619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Utility-Based Dose Selection for Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma"],"prefix":"10.1016","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0194-8381","authenticated-orcid":false,"given":"Alex K.","family":"Bryant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Matuszak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teodor","family":"Stanescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janell S.","family":"Dow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neehar D.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Cuneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles S.","family":"Mayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore S.","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Schipper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2025.07.1408_bib0001","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13014-019-1318-9","article-title":"Calculating the individualized fraction regime in stereotactic body radiotherapy for non-small cell lung cancer based on uncomplicated tumor control probability function","volume":"14","author":"Lu","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2025.07.1408_bib0002","article-title":"Analysis of hepatocellular carcinoma stereotactic body radiation therapy dose prescription method using uncomplicated tumor control probability model","volume":"6","author":"Cheung","year":"2021","journal-title":"Adv Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ijrobp.2025.07.1408_bib0003","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/jamaoncol.2017.2303","article-title":"Individualized adaptive stereotactic body radiotherapy for liver tumors in patients at high risk for liver damage: A phase 2 clinical trial","volume":"4","author":"Feng","year":"2018","journal-title":"JAMA Oncology"},{"key":"10.1016\/j.ijrobp.2025.07.1408_bib0004","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","article-title":"Assessment of liver function in patients with hepatocellular carcinoma: A new evidence-based approach-the ALBI grade","volume":"33","author":"Johnson","year":"2015","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ijrobp.2025.07.1408_bib0005","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijrobp.2021.04.012","article-title":"The potential for midtreatment Albumin-Bilirubin (ALBI) score to individualize liver stereotactic body radiation therapy","volume":"111","author":"Jackson","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.07.1408_bib0006","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejca.2020.04.024","article-title":"Long term outcomes of stereotactic body radiation therapy for hepatocellular carcinoma without macrovascular invasion","volume":"134","author":"Mathew","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2025.07.1408_bib0007","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1080\/02841860600936369","article-title":"Individualized image guided iso-NTCP based liver cancer SBRT","volume":"45","author":"Dawson","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2025.07.1408_bib0008","doi-asserted-by":"crossref","first-page":"8739","DOI":"10.1200\/JCO.2005.01.5354","article-title":"Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies","volume":"23","author":"Ben-Josef","year":"2005","journal-title":"J Clin Oncol"},{"issue":"suppl","key":"10.1016\/j.ijrobp.2025.07.1408_bib0009","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1200\/JCO.2023.41.4_suppl.489","article-title":"NRG\/RTOG 1112: Randomized phase III study of sorafenib vs. stereotactic body radiation therapy (SBRT) followed by sorafenib in hepatocellular carcinoma (HCC)","volume":"41","author":"Dawson","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2025.07.1408_bib0010","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000036705","article-title":"Analysis of competing risks of cardiovascular death in patients with hepatocellular carcinoma: A population-based study","volume":"102","author":"Cao","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijrobp.2025.07.1408_bib0011","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.ijrobp.2025.07.1408_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1427332","article-title":"The role of ALBI score in patients treated with stereotactic body radiotherapy for locally advanced primary liver tumors: A pooled analysis of two prospective studies","volume":"14","author":"Gkika","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2025.07.1408_bib0013","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/jrr\/rrae006","article-title":"Albumin-bilirubin score is a useful predictor of worsening liver reserve after stereotactic body radiation therapy in elderly Japanese patients with hepatocellular carcinoma","volume":"65","author":"Yoshino","year":"2024","journal-title":"J Radiat Res"},{"key":"10.1016\/j.ijrobp.2025.07.1408_bib0014","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.ijrobp.2018.04.011","article-title":"Baseline albumin-bilirubin (ALBI) score in Western patients with hepatocellular carcinoma treated with stereotactic body radiation therapy (SBRT)","volume":"101","author":"Murray","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2025.07.1408_bib0015","doi-asserted-by":"crossref","first-page":"6279","DOI":"10.1002\/mp.15940","article-title":"Direct incorporation of patient-specific efficacy and toxicity estimates in radiation therapy plan optimization","volume":"49","author":"Polan","year":"2022","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2025.07.1408_bib0016","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1002\/sim.6285","article-title":"Personalized dose selection in radiation therapy using statistical models for toxicity and efficacy with dose and biomarkers as covariates","volume":"33","author":"Schipper","year":"2014","journal-title":"Stat Med"},{"key":"10.1016\/j.ijrobp.2025.07.1408_bib0017","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.0006-341X.2004.00218.x","article-title":"Dose-finding based on efficacy-toxicity trade-offs","volume":"60","author":"Thall","year":"2004","journal-title":"Biometrics"},{"key":"10.1016\/j.ijrobp.2025.07.1408_bib0018","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/17407745231207085","article-title":"Statistical and practical considerations in planning and conduct of dose-optimization trials","volume":"21","author":"Yuan","year":"2024","journal-title":"Clin Trials"},{"key":"10.1016\/j.ijrobp.2025.07.1408_bib0019","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1002\/sim.9396","article-title":"Utility based approach in individualized optimal dose selection using machine learning methods","volume":"41","author":"Li","year":"2022","journal-title":"Stat Med"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301625060067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301625060067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:18:44Z","timestamp":1780388324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301625060067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0360301625060067"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.07.1408","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utility-Based Dose Selection for Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2025.07.1408","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}